These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Defining the complement biomarker profile of C3 glomerulopathy. Zhang Y, Nester CM, Martin B, Skjoedt MO, Meyer NC, Shao D, Borsa N, Palarasah Y, Smith RJ. Clin J Am Soc Nephrol; 2014 Nov 07; 9(11):1876-82. PubMed ID: 25341722 [Abstract] [Full Text] [Related]
13. Long-term follow-up including extensive complement analysis of a pediatric C3 glomerulopathy cohort. Michels MAHM, Wijnsma KL, Kurvers RAJ, Westra D, Schreuder MF, van Wijk JAE, Bouts AHM, Gracchi V, Engels FAPT, Keijzer-Veen MG, Dorresteijn EM, Volokhina EB, van den Heuvel LPWJ, van de Kar NCAJ. Pediatr Nephrol; 2022 Mar 07; 37(3):601-612. PubMed ID: 34476601 [Abstract] [Full Text] [Related]
14. CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis. Piras R, Breno M, Valoti E, Alberti M, Iatropoulos P, Mele C, Bresin E, Donadelli R, Cuccarolo P, Smith RJH, Benigni A, Remuzzi G, Noris M. Front Genet; 2021 Mar 07; 12():670727. PubMed ID: 34211499 [Abstract] [Full Text] [Related]
15. Clinicopathological features of C3 glomerulopathy in children: a single-center experience. Drake KA, Ellington N, Gattineni J, Torrealba JR, Hendricks AR. Pediatr Nephrol; 2020 Jan 07; 35(1):153-162. PubMed ID: 31667615 [Abstract] [Full Text] [Related]
16. Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents. Holle J, Berenberg-Goßler L, Wu K, Beringer O, Kropp F, Müller D, Thumfart J. Pediatr Nephrol; 2018 Dec 07; 33(12):2289-2298. PubMed ID: 30238151 [Abstract] [Full Text] [Related]
17. C3 Glomerulopathy. Riedl M, Thorner P, Licht C. Pediatr Nephrol; 2017 Jan 07; 32(1):43-57. PubMed ID: 27056062 [Abstract] [Full Text] [Related]